申请人:ALLERGAN, INC.
公开号:EP2955173A1
公开(公告)日:2015-12-16
The present invention relates to novel bis-sulfonamide derivatives of Formula I, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.
本发明涉及式 I 的新型双磺酰胺衍生物、其制备工艺、含有它们的药物组合物以及它们作为趋化因子受体调节剂的药物用途。